Detected ·
Abbmira Therapeutics
CHF 800K—
Basel-based biotech Abbmira Therapeutics, founded by Julia Biwer and Marc Creus, is currently raising a CHF 800K pre-seed round to develop immunotherapies that help the immune system fight cancer.
- Website
- www.abbmira.com
- linkedin.com/company/abbmira
- Amount
- CHF 800 000 CHF
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-02 12:02:41 UTC
- Signal ID
- c0b9d286-3415-486d-ae2d-5047546c27e3
As the API returns it
{
"id": "c0b9d286-3415-486d-ae2d-5047546c27e3",
"created_at": "2026-09-02T12:02:41.540888Z",
"company_name": "Abbmira Therapeutics",
"company_website_url": "www.abbmira.com",
"company_linkedin_url": "https://www.linkedin.com/company/abbmira",
"event_type": "funding",
"funding_amount": 800000,
"funding_currency": "CHF",
"funding_stage": null,
"message": "*Basel-based biotech Abbmira Therapeutics, founded by Julia Biwer and Marc Creus, is currently raising a CHF 800K pre-seed round to develop immunotherapies that help the immune system fight cancer.*"
}